Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06454227

Subcutaneous Lavage in Cesarean Section

The goal of this clinical trial is to learn if antiseptic washing prior to skin closure during cesarean section reduces rates of surgical site infection.

intraoperative washing is a common practice in other surgical fields and several studies have shown efficacy in reducing postoperative infection rates. no randomized control trial has tested this intervention during cesarean section.

The main questions we aim to answer are:

Does subcutaneous antiseptic washing reduce the rates of surgical site infection? Does antiseptic washing improve scar healing? Does antiseptic washing reduce hospital stay, postpartum fever rates and readmission cases?

Researchers will compare subcutaneous antiseptic washing to no intervention to see if surgical site infection rates reduce

Participants will:

consent to participate in the trial Visit the postpartum clinic 30 days after surgery

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Surgical Site Infection Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Surgical Wound Infection Wound Infection

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • pregnant women undergoing cesarean delivery

Exclusion criteria

  • pregnant women undergoing vaginal delivery

Treatment and study plan

Subcutaneous washing

Procedure

subcutaneous washing with chlorhexidine gluconate prior to skin closure

no subcutaneous washing

Procedure

no washing

Primary outcomes

  1. surgical site infection

    Time frame: 30 days after surgery

    SSI infection rates

Secondary outcomes

  1. hospital stay

    Time frame: 30 days after surgery

    length of hospital stay

  2. wound healing

    Time frame: 30 days after surgery

    assessment of the healing according to Southampton criteria: presence of inflammation, erythema or discharge

  3. postpartum fever

    Time frame: 30 days after surgery

    fever recording

Sponsors and collaborators

Lead sponsor

Hadassah Medical Organization

Other

Registry information

Official study title

Antiseptic Washing Prior to Skin Closure During Cesarean Delivery- a Randomized Control Trial

Important dates

Study start
2024
Primary completion
2027
Study completion
2028
First posted
Jun 12, 2024
Registry last updated
Mar 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.